Oxford/Astrazeneca COVID-19 vaccine less effective against S.African variant: FT cites study
Reuters, , Saturday 6 Feb 2021

The COVID-19 vaccine developed by AstraZeneca and Oxford University does not appear to protect against mild and moderate disease caused by the South African coronavirus variant, the Financial Times reported on Saturday, citing a study due to be published on Monday.